Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Indaco Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 4
Rounds per year 0.50
Lead investments 0
Key employees Soon

Areas of investment

  • Health Care
  • Medical
  • Biotechnology
  • Pharmaceutical

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aetna Ventures Connecticut, Hartford, United States
Agentschap NL -
Beijing Wojia Xinxi Zixun Zhongxin Beijing, China, Haidian
Bitclick GmbH -
Cali Group California, Pasadena, United States
Double Peak Group China, Hong Kong, Hong Kong Island
Framework Ventures Canada, Ontario, Toronto
Insight Catastrophe Group Jersey City, New Jersey, United States
Keller Capital Austin, Texas, United States
KJS Ahluwalia Group India, Keonjhar, Odisha
Lezhong Investment Management China, Guangdong, Zhuhai
NBK Capital Partners Dubai, United Arab Emirates
NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) Arlington, United States, Virginia
Pierpoint Capital New York, New York, United States
Skyviews Life Science -
Spectra Investments Brazil, São Paulo, Sao Paulo
True North Venture Partners Chicago, Illinois, United States
WuXi PharmaTech China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ReLive

Biotechnology
Health Care
Medical
$36M16 Jan 2023 -

Zenshine Pharma

Health Care
Medical
Pharmaceutical
$15M01 Dec 2020 Nanjing, Jiangsu, China

Delova Biotech

Biotechnology
Health Care
Medical
$7M21 Sep 2020 -

09 Apr 2020 Haidian District, Beijing, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Indaco Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: